| 期刊論文1. | Cheng, S. C.、Chang, Y. C.、Chiang, Yu-Long Fan(2020)。First case of coronavirus disease 2019 (COVID-19) pneumonia in Taiwan。J Formos Med Assoc,119(3),747-751。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 2. | Zhu, Na、Zhang, Dingyu、Wang, Wenling、Li, Xingwang、Yang, Bo、Song, J.、Zhao, X.、Huang, B.、Shi, W.、Lu, R.、Niu, P.、Zhan, F.、Ma, X.、Wang, D.、Xu, W.、Wu, G.、Gao, George F.、Tan, W.(2020)。A novel coronavirus from patients with pneumonia in China, 2019。The New England Journal of Medicine,382(8),727-733。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 3. | Kao, H. Y.、Ko, H. Y.、Guo, P.、Chen, C. H.、Chou, S. M.(2017)。Taiwan's Experience in Hospital Preparedness and Response for Emerging Infectious Diseases。Health Secur,15,175-184。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 4. | Chen, C. P.、Lin, Y. P.、Chen, T. C.(2020)。A Multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate Coronavirus disease 2019 (COVID-19)。PLoS ONE,15(12)。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 5. | Folegatti, P. M.、Ewer, K. J.、Aley, P. K.(2020)。Safety and immunogenicity of the ChAdOxl nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial。Lancet,396,467-478。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 6. | Cohen, J.(2020)。Vaccine designers take first shots at COVID-19。Science,368,14-16。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 7. | Le, Tung Thanh、Andreadakis, Zacharias、Kumar, Arun、Román, Raúl Gómez、Tollefsen, Stig、Saville, Melanie、Mayhew, Stephen(20200409)。The COVID-19 vaccine development landscape。Nature Reviews Drug Discovery,19,305-306。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 8. | Nichol, A. A.(2020)。Potential implications of testing an experimental mRNA-based vaccine during an emerging infectious disease pandemic。Am J Bioeth,20(7),W2-W3。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 9. | Jackson, L. A.、Anderson, E. J.、Rouphael, N. G.(2020)。An mRNA vaccine against SARS-CoV-2-preliminary report。N Engl J Med,383,1920-1931。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 其他1. | 衛生福利部疾病管制署(2020)。傳染病防治醫療網推動計畫109年修訂版,https://www.cdc.gov.tw/Category/Page/fuHFX9R-pd4846Y_vLPmJA, 。 延伸查詢![new window](/gs32/images/newin.png) | |